Filing

Apimeds Pharmaceuticals US, Inc. Filed 2025-05-15 Acc 0001213900-25-044254

Documents 1

2025-08-14 NT 10-Q NT 10-Q
2025-05-15 4 Chairman and CMO bought 27,500 shares at an average $1.83 ($50,359)
2025-05-15 NT 10-Q NT 10-Q
2025-05-14 4 Director bought 28,500 shares at $1.99 ($56,715)
2025-05-14 4 10% owner bought 500,000 shares at $4.00 ($2,000,000)
2025-05-14 3/A 3/A
2025-05-12 8-K Material agreement · Unregistered share sale · Regulation FD disclosure

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading ea0242447-nt10q_apimeds.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…